The global metabolism assays market is poised for robust growth, projected to reach US$ 3.1 Billion by 2034. Driven by the increasing prevalence of metabolic disorders like obesity, type 2 diabetes, and hypertension, the demand for these analytical tools is surging. Advancements in technology, particularly in NMR spectroscopy, are further fueling market expansion. This report delves into the market’s key drivers, regional insights, and leading players.